iShares US Pharmaceuticals ETF
IHE
IHE
102 hedge funds and large institutions have $311M invested in iShares US Pharmaceuticals ETF in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 30 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6.69% more ownership
Funds ownership: 105.34% → 112.03% (+6.7%)
3% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 30
Holders
102
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$15.6M | |
| 2 | +$12.4M | |
| 3 | +$4.35M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$3.58M |
| 5 |
SG Americas Securities
New York
|
+$2.93M |
Top Sellers
| 1 | -$12.5M | |
| 2 | -$2.85M | |
| 3 | -$2.69M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$2.38M |
| 5 |
Morgan Stanley
New York
|
-$838K |